Who
George Adi Mor
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Chemomab Therapeutics.
In numbers
- Trades disclosed
- 16
- Buys
- 1
- Sells
- 2
- Bought
- $40K
- Sold
- $1.3M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 28 Oct 2016
- Last trade
- 29 May 2026
- Last filed
- 1 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 29 May 2026filed 1 Jun 2026 | CMMB Chemomab TherapeuticsBiotechnology | SEC FORM 4 Bought | $10,0004,878 at $2.05 | filing |
| 29 May 2026filed 1 Jun 2026 | CMMB Chemomab TherapeuticsBiotechnology | SEC FORM 4 Bought | $10K4,926 at $2.08 | filing |
| 29 May 2026filed 1 Jun 2026 | CMMB Chemomab TherapeuticsBiotechnology | SEC FORM 4 Code J | —31,712 | filing |
| 29 May 2026filed 1 Jun 2026 | CMMB Chemomab TherapeuticsBiotechnology | SEC FORM 4 Code J | —18,750 | filing |
| 29 May 2026filed 1 Jun 2026 | CMMB Chemomab TherapeuticsBiotechnology | SEC FORM 4 Bought | $10,0004,878 at $2.05 | filing |
| 29 May 2026filed 1 Jun 2026 | CMMB Chemomab TherapeuticsBiotechnology | SEC FORM 4 Bought | $10K4,926 at $2.08 | filing |
| 29 May 2026filed 1 Jun 2026 | CMMB Chemomab TherapeuticsBiotechnology | SEC FORM 4 Code J | —31,712 | filing |
| 29 May 2026filed 1 Jun 2026 | CMMB Chemomab TherapeuticsBiotechnology | SEC FORM 4 Code J | —18,750 | filing |
| 3 Jan 2023filed 5 Jan 2023 | CMMB Chemomab TherapeuticsBiotechnology | SEC FORM 4 Sold | $39K7,700 at $5.03 | filing |
| 3 Jan 2023filed 5 Jan 2023 | CMMB Chemomab TherapeuticsBiotechnology | SEC FORM 4 Sold | $31K6,100 at $5.03 | filing |
| 16 Nov 2022filed 17 Nov 2022 | CMMB Chemomab TherapeuticsBiotechnology | SEC FORM 4 Sold | $676K324,775 at $2.08 | filing |
| 16 Nov 2022filed 17 Nov 2022 | CMMB Chemomab TherapeuticsBiotechnology | SEC FORM 4 Sold | $535K257,248 at $2.08 | filing |
| 15 Mar 2018filed 5 Jan 2023 | CMMB Chemomab Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —131,698 at $0.00 | filing |
| 15 Mar 2018filed 17 Nov 2022 | CMMB Chemomab Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —131,698 at $0.00 | filing |
| 28 Oct 2016filed 5 Jan 2023 | CMMB Chemomab Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —33,725 at $0.00 | filing |
| 28 Oct 2016filed 17 Nov 2022 | CMMB Chemomab Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —33,725 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.